# RADICALPC (NCT03127631)

> A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

No report yet. It can be ordered.

- Indication: prostate cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03127631
- Phase: NA
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: McMaster University
- Conditions: Prostate Cancer; Cardiovascular Disease
- Interventions: Nutrition; Exercise; Smoking cessation; Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin); ACE inhibitor
- Enrollment: 5000
- Primary outcome: Hierarchical composite of cardiovascular death, myocardial infarction, stroke, heart failure, cholesterol control (defined as total cholesterol ≤4mmol/L) and systolic blood pressure control (defined as systolic blood pressure ≤130mmHg).
- Primary outcome: Time to the first occurrence of the composite of cardiovascular death, myocardial infarction, stroke, heart failure.

## Indexed commentary on RADICALPC so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 9 posts on X
- 2 podcast episodes

## Order

Standard, $1,250 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=radicalpc-nct03127631

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03127631", "email": "<work email>"}; the inbox owner confirms by the emailed link.